Tag: paritaprevir
-
Study Suggests Alternative to Common HCV Treatment with Equally High SVR, No PPI Modification Needed
American College of Gastroenterology / Posts / Uncategorized / Study Suggests Alternative to Common HCV Treatment with Equally High SVR, No PPI Modification NeededPoster 413 Efficacy of Ombitasvir/Paritaprevir/ and Dasabuvir +/-Ribavirin in Patients Receiving Concomitant Acid-Reducing Agents in Phase 3 Trials Author Insight…
-
American College of Gastroenterology / Posts / Uncategorized / Study Suggests All-Oral Therapy for HCV G1 Patients is Highly Effective, Regardless of Race or Ethnicity
Oral 65 High SVR Rates Among US Patients Regardless of Race or Ethnicity in HCV GT1 Patients Receiving the Label-Recommended…